4,538
Participants
Start Date
October 10, 2012
Primary Completion Date
February 3, 2015
Study Completion Date
August 18, 2015
Priorix
Subjects receive one dose of either minimum (Inv\_MMR\_Min) or medium (Inv\_MMR\_Med) potency lot at Day 0 and a dose of separate potency lot (Inv\_MMR\_Release) at Day 42, administered subcutaneously in the triceps region of the left arm.
M-M-R II
Subjects receive two doses of either Lot 1 or Lot 2, one at Day 0 and one at Day 42, administered subcutaneously in the triceps region of the left arm.
Varivax
Subjects receive one dose co-administered subcutaneously with the study vaccines (Priorix and M-M-R II), in the triceps region of right arm, at Day 0.
Havrix
Subjects receive one dose co-administered intramuscularly with the study vaccines (Priorix and M-M-R II), in the anterolateral region of the right thigh, at Day 0.
Prevnar 13
US Subjects receive one dose co-administered intramuscularly with the study vaccines (Priorix and M-M-R II), in the anterolateral region of the left thigh, at Day 0.
GSK Investigational Site, Prague
GSK Investigational Site, Bangkok
GSK Investigational Site, Bangkok
GSK Investigational Site, Bangkok
GSK Investigational Site, Pathum Thani
GSK Investigational Site, Santiago de Compostela
GSK Investigational Site, Johnstown
GSK Investigational Site, Kuala Terengganu
GSK Investigational Site, Turku
GSK Investigational Site, Baltimore
GSK Investigational Site, Annapolis
GSK Investigational Site, Frederick
GSK Investigational Site, Midlothian
GSK Investigational Site, Richmond
GSK Investigational Site, Odolena Voda
GSK Investigational Site, Clyde
GSK Investigational Site, Antequera/Málaga
GSK Investigational Site, Charleston
GSK Investigational Site, Charleston
GSK Investigational Site, Altamonte Springs
GSK Investigational Site, Miami Lakes
GSK Investigational Site, Tampere
GSK Investigational Site, Miami
GSK Investigational Site, Tampa
GSK Investigational Site, Naples
GSK Investigational Site, Birmingham
GSK Investigational Site, Jindřichův Hradec
GSK Investigational Site, Louisville
GSK Investigational Site, Seville
GSK Investigational Site, Toledo
GSK Investigational Site, Cleveland
GSK Investigational Site, Youngstown
GSK Investigational Site, Dayton
GSK Investigational Site, Dayton
GSK Investigational Site, Liberec
GSK Investigational Site, Valencia
GSK Investigational Site, Valencia
GSK Investigational Site, L'Eliana, Valencia
GSK Investigational Site, Valencia
GSK Investigational Site, Quart de Poblet, Valencia
GSK Investigational Site, New Albany
GSK Investigational Site, Chiang Mai
GSK Investigational Site, West Des Moines
GSK Investigational Site, Chlumec nad Cidlinou
GSK Investigational Site, Kansas City
GSK Investigational Site, Wichita
GSK Investigational Site, Omaha
GSK Investigational Site, Lincoln
GSK Investigational Site, Lincoln
GSK Investigational Site, Ostrava - Poruba
GSK Investigational Site, Little Rock
GSK Investigational Site, Jonesboro
GSK Investigational Site, Lipník nad Bečvou
GSK Investigational Site, Houston
GSK Investigational Site, Layton
GSK Investigational Site, Springville
GSK Investigational Site, St. George
GSK Investigational Site, Phoenix
GSK Investigational Site, Phoenix
GSK Investigational Site, Oulu
GSK Investigational Site, West Covina
GSK Investigational Site, Kuching
GSK Investigational Site, Sibu
GSK Investigational Site, Gresham
GSK Investigational Site, Ellensburg
GSK Investigational Site, Muncie
GSK Investigational Site, Benešov
GSK Investigational Site, Děčín
GSK Investigational Site, Kladno
GSK Investigational Site, Náchod
GSK Investigational Site, Pardubice
GSK Investigational Site, Helsinki
GSK Investigational Site, Helsinki
GSK Investigational Site, Järvenpää
GSK Investigational Site, Guayama
GSK Investigational Site, Ponce
GSK Investigational Site, San Juan
GSK Investigational Site, Barcelona
GSK Investigational Site, Centelles (Barcelona)
GSK Investigational Site, Manlleu
GSK Investigational Site, Vic
Lead Sponsor
GlaxoSmithKline
INDUSTRY